Literature DB >> 21801386

Primary leiomyosarcoma of the seminal vesicle: case report and review of the literature.

Cécile Cauvin1, Laurence Moureau-Zabotto, Bruno Chetaille, Werner Hilgers, Yves Denoux, Jocelyne Jacquemier, Jérôme Guiramand, Anthony Sarran, François Bertucci.   

Abstract

BACKGROUND: Primary leiomyosarcoma of the seminal vesicle is exceedingly rare. CASE
PRESENTATION: We report a case of a 59-year-old man with tumour detected by rectal symptoms and ultrasonography. Computed tomography and magnetic resonance imaging suggested an origin in the right seminal vesicle. Transperineal biopsy of the tumour revealed leiomyosarcoma. A radical vesiculo-prostactectomy with bilateral pelvic lymphadenectomy was performed. Pathological examination showed a grade 2 leiomyosarcoma of the seminal vesicle. The patient received adjuvant radiotherapy. He developed distant metastases 29 months after diagnosis, and received chemotherapy. Metastatic disease was controlled by second-line gemcitabine-docetaxel combination. Fifty-one months after diagnosis of the primary tumour, and 22 months after the first metastases, the patient is alive with excellent performance status, and multiple asymptomatic stable lung and liver lesions.
CONCLUSIONS: We report the eighth case of primary leiomyosarcoma of the seminal vesicle and the first one with a so long follow-up.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21801386      PMCID: PMC3161040          DOI: 10.1186/1471-2407-11-323

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  10 in total

1.  Primary leiomyosarcoma of the seminal vesicle.

Authors:  M Muentener; S Hailemariam; M Dubs; D Hauri; T Sulser
Journal:  J Urol       Date:  2000-12       Impact factor: 7.450

2.  Adult urological sarcoma.

Authors:  P Russo; M S Brady; K Conlon; S I Hajdu; W R Fair; H W Herr; M F Brennan
Journal:  J Urol       Date:  1992-04       Impact factor: 7.450

3.  Imaging of primary leiomyosarcoma of the seminal vesicle.

Authors:  Lalendra Upreti; Satish K Bhargava; Atin Kumar
Journal:  Australas Radiol       Date:  2003-03

4.  Primary leiomyosarcoma of the seminal vesicle.

Authors:  R H Amirkhan; K H Molberg; E L Wiley; P Nurenberg; A I Sagalowsky
Journal:  Urology       Date:  1994-07       Impact factor: 2.649

Review 5.  Local management of adult soft tissue sarcomas.

Authors:  Carol J Swallow; Charles N Catton
Journal:  Semin Oncol       Date:  2007-06       Impact factor: 4.929

Review 6.  Primary adenocarcinoma of the seminal vesicles.

Authors:  Ralf Thiel; Peter Effert
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

7.  Primary leiomyosarcoma of the seminal vesicle.

Authors:  Vivek Agrawal; Sunil Kumar; Deborshi Sharma; Usha Rani Singh; Arun Gupta
Journal:  Int J Urol       Date:  2004-04       Impact factor: 3.369

Review 8.  Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven.

Authors:  Jean-Yves Blay; Axel Le Cesne
Journal:  Oncologist       Date:  2009-10-06

9.  Primary leiomyosarcoma of the seminal vesicle.

Authors:  A R Schned; J S Ledbetter; S M Selikowitz
Journal:  Cancer       Date:  1986-06-01       Impact factor: 6.860

10.  Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

Authors:  Martee L Hensley; Robert Maki; E Venkatraman; Gennifer Geller; Meghan Lovegren; Carol Aghajanian; Paul Sabbatini; William Tong; Richard Barakat; David R Spriggs
Journal:  J Clin Oncol       Date:  2002-06-15       Impact factor: 44.544

  10 in total
  2 in total

1.  Primary squamous cell carcinoma of the seminal vesicle: A case report.

Authors:  Kaifa Tang; F A Sun; Yuan Tian; Yuehai Xiao; Chao Sun; Pengfei Wang
Journal:  Mol Clin Oncol       Date:  2015-12-15

Review 2.  Detecting diseases of neglected seminal vesicles using imaging modalities: A review of current literature.

Authors:  Gautam Dagur; Kelly Warren; Yiji Suh; Navjot Singh; Sardar A Khan
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.